These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33999721)

  • 1. Herd Immunity Against COVID-19: More Questions Than Answers.
    Russell RS
    Viral Immunol; 2021 May; 34(4):211-212. PubMed ID: 33999721
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving and sustaining herd immunity to SARS-CoV-2.
    Bolotin S; Wilson S; Murti M
    CMAJ; 2021 Jul; 193(28):E1089. PubMed ID: 34281966
    [No Abstract]   [Full Text] [Related]  

  • 3. The dilemma of herd immunity for COVID-19.
    Nejadghaderi SA; Safiri S
    J Med Virol; 2021 May; 93(5):2578-2579. PubMed ID: 33386744
    [No Abstract]   [Full Text] [Related]  

  • 4. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
    Yewdell JW
    PLoS Pathog; 2021 Apr; 17(4):e1009509. PubMed ID: 33901246
    [No Abstract]   [Full Text] [Related]  

  • 5. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Yin and Yang and Herd Immunity.
    James JJ
    Disaster Med Public Health Prep; 2020 Dec; 14(6):e12-e14. PubMed ID: 32631463
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and immunity: quo vadis?
    Miyasaka M
    Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad M; Al-Saqqaf IS
    Int J Infect Dis; 2021 May; 106():79-82. PubMed ID: 33737135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Understand Herd Immunity in the Context of COVID-19.
    Dong M; He F; Deng Y
    Viral Immunol; 2021 Apr; 34(3):174-181. PubMed ID: 33351708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.
    Black JT; Haroon U; Barnes SC; Mayaleh S; Bagul A
    Transpl Int; 2021 Feb; 34(2):382-383. PubMed ID: 33320975
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of Herd Immunity to COVID-19 in Louisiana Nursing Homes.
    Reilly TA
    J Am Med Dir Assoc; 2021 Feb; 22(2):256-257. PubMed ID: 33358724
    [No Abstract]   [Full Text] [Related]  

  • 12. Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control.
    de Vlas SJ; Coffeng LE
    Sci Rep; 2021 Feb; 11(1):4445. PubMed ID: 33627674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd Immunity to COVID-19.
    Kadkhoda K
    Am J Clin Pathol; 2021 Mar; 155(4):471-472. PubMed ID: 33399182
    [No Abstract]   [Full Text] [Related]  

  • 14. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming COVID-19 in West African countries: is herd immunity an option?
    Ilesanmi OS; Akande A; Afolabi AA
    Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
    Mveang Nzoghe A; Leboueny M; Kuissi Kamgaing E; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Padzys GS; Ndeboko B; Ategbo S; Djoba Siawaya JF
    BMC Res Notes; 2021 Apr; 14(1):152. PubMed ID: 33879229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital herd immunity and COVID-19.
    Bulchandani VB; Shivam S; Moudgalya S; Sondhi SL
    Phys Biol; 2021 Jun; 18(4):. PubMed ID: 33827059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.